QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 25, 2004, 24(8):1888-1896; doi:10.1523/JNEUROSCI.3809-03.2004

This Article Full Text Full Text (PDF) Supplementary Fig. 1 Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (65) Citing Articles via Google Scholar Google Scholar Articles by Lee, H.-J. Articles by Lee, S.-J. Search for Related Content PubMed PubMed Citation Articles by Lee, H.-J. Articles by Lee, S.-J.

 Previous Article  |  Next Article 

Cellular/Molecular
Clearance of -Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway

He-Jin Lee, Farnaz Khoshaghideh, Smita Patel, and Seung-Jae Lee

The Parkinson's Institute, Sunnyvale, California 94089

Cytoplasmic deposition of -synuclein aggregates is a common pathological feature of many neurodegenerative diseases. Strong evidence for the causative role of -synuclein in these disorders is provided by genetic linkage between this gene and familial Parkinson's disease and by neurodegeneration in transgenic animals that overexpress this protein. In particular, it has been hypothesized that the accumulation of nonfibrillar oligomers of -synuclein, which serve as intermediates for fibrillar inclusion body formation, causes neurodegeneration. However, little is known about how cells handle potentially toxic protein aggregates. Here we demonstrate that cells are capable of clearing preformed -synuclein aggregates via the lysosomal degradation pathway. Consequently, blocking this pathway causes the accumulation of the aggregates in non-neuronal cells, differentiated neuroblastoma cells, and primary cortical neurons. This aggregate clearance occurs in an aggregation stage-specific manner; oligomeric intermediates are susceptible to clearance, whereas mature fibrillar inclusion bodies are not. Neutralization of the acidic compartments leads to the accumulation of -synuclein aggregates and exacerbates -synuclein toxicity in postmitotic neuronal cells, suggesting that the accumulation of oligomeric intermediates may be an important event leading to -synuclein-mediated cell death. These results suggest that enhancing lysosomal function may be a potential therapeutic strategy to halt or even prevent the pathogenesis of Parkinson's disease and other Lewy body diseases.

Key words: -synuclein; protein aggregation; lysosome; Parkinson's disease; Lewy body; neurodegeneration

---

Received Aug 14, 2003; revised December 23, 2003; accepted December 23, 2003.

This article has been cited by other articles:

				P. Desplats, H.-J. Lee, E.-J. Bae, C. Patrick, E. Rockenstein, L. Crews, B. Spencer, E. Masliah, and S.-J. Lee From the Cover: Inclusion formation and neuronal cell death through neuron-to-neuron transmission of {alpha}-synuclein PNAS, August 4, 2009; 106(31): 13010 - 13015. [Abstract] [Full Text] [PDF]

				C. L. Kragh, L. B. Lund, F. Febbraro, H. D. Hansen, W.-P. Gai, O. El-Agnaf, C. Richter-Landsberg, and P. H. Jensen {alpha}-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells J. Biol. Chem., April 10, 2009; 284(15): 10211 - 10222. [Abstract] [Full Text] [PDF]

				S. Azeredo da Silveira, B. L. Schneider, C. Cifuentes-Diaz, D. Sage, T. Abbas-Terki, T. Iwatsubo, M. Unser, and P. Aebischer Phosphorylation does not prompt, nor prevent, the formation of {alpha}-synuclein toxic species in a rat model of Parkinson's disease Hum. Mol. Genet., March 1, 2009; 18(5): 872 - 887. [Abstract] [Full Text] [PDF]

				T. Pan, S. Kondo, W. Le, and J. Jankovic The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease Brain, August 1, 2008; 131(8): 1969 - 1978. [Abstract] [Full Text] [PDF]

				S. Hamamichi, R. N. Rivas, A. L. Knight, S. Cao, K. A. Caldwell, and G. A. Caldwell Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model PNAS, January 15, 2008; 105(2): 728 - 733. [Abstract] [Full Text] [PDF]

				J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies J. Biol. Chem., September 28, 2007; 282(39): 28904 - 28914. [Abstract] [Full Text] [PDF]

				A. Di Fonzo, H. F. Chien, M. Socal, S. Giraudo, C. Tassorelli, G. Iliceto, G. Fabbrini, R. Marconi, E. Fincati, G. Abbruzzese, et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease Neurology, May 8, 2007; 68(19): 1557 - 1562. [Abstract] [Full Text] [PDF]

				J. Klucken, T. F. Outeiro, P. Nguyen, P. J. McLean, and B. T. Hyman Detection of novel intracellular {alpha}-synuclein oligomeric species by fluorescence lifetime imaging FASEB J, October 1, 2006; 20(12): 2050 - 2057. [Abstract] [Full Text] [PDF]

				R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy. J. Neurosci., April 5, 2006; 26(14): 3685 - 3696. [Abstract] [Full Text] [PDF]

				H.-J. Lee, S. Patel, and S.-J. Lee Intravesicular Localization and Exocytosis of {alpha}-Synuclein and its Aggregates J. Neurosci., June 22, 2005; 25(25): 6016 - 6024. [Abstract] [Full Text] [PDF]

				W. Li, N. West, E. Colla, O. Pletnikova, J. C. Troncoso, L. Marsh, T. M. Dawson, P. Jakala, T. Hartmann, D. L. Price, et al. Aggregation promoting C-terminal truncation of {alpha}-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations PNAS, February 8, 2005; 102(6): 2162 - 2167. [Abstract] [Full Text] [PDF]

				A. M. Cuervo, L. Stefanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer Impaired Degradation of Mutant {alpha}-Synuclein by Chaperone-Mediated Autophagy Science, August 27, 2004; 305(5688): 1292 - 1295. [Abstract] [Full Text] [PDF]

				W. Li, C. Lesuisse, Y. Xu, J. C. Troncoso, D. L. Price, and M. K. Lee Stabilization of {alpha}-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation J. Neurosci., August 18, 2004; 24(33): 7400 - 7409. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help